New MDMA variants could be promising alternatives for safe psychotherapeutic applications

FHS
June 25, 2024
3:05 pm

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as “ecstasy”, to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.

Canadian cannabis producer Green Karat enters German craft cannabis market in partnership with Cantourage – Biotech Investments

EQS-News: Cantourage Group SE / Key word(s): Market Launch Canadian cannabis producer Green Karat enters German craft cannabis market in partnership with Cantourage 20.06.2023 /

June 21, 2023

FDA Outlines Rules for Telling Clinicians About Unapproved Uses of Drugs, Devices

The FDA has released revised draft guidance on communicating with healthcare professionals (HCPs) about unapproved uses of approved drugs and devices. Once it’s finalized, the

November 1, 2023

UNH research seeks to quantify health outcomes based on food access, fiber intake and gut microbiota

The U.S. obesity epidemic continues to have profound impacts on individuals’ health and socioeconomic well-being

September 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.